Clinical Trial Update: Efficacy and Safety of Tralokinumab Administered by an Autoinjector in Adults and Adolescents With Moderate to Severe Atopic Dermatitis (INJECZTRA) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial INJECZTRA assessed efficacy and safety of autoinjector-administered tralokinumab in adults and adolescents with moderate-to-severe atopic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Tralokinumab (tralokinumab)

Snippet

Sponsor: LEO Pharma | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2024-06-20